Kenji Nagino, Tadaishi Koh, Yasushi Harada. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AnimalsBehavior, Animal/drug effectsCatalepsy/chemically inducedClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicDouble-Blind MethodHumansIsoxazoles/administration & dosageIsoxazoles/adverse effectsIsoxazoles/metabolismIsoxazoles/pharmacologyIsoxazoles/therapeutic usePaliperidone PalmitatePyrimidines/administration & dosagePyrimidines/adverse effectsPyrimidines/metabolismPyrimidines/pharmacologyPyrimidines/therapeutic useRandomized Controlled Trials as TopicReceptor, Serotonin, 5-HT2A/metabolismReceptors, Dopamine D2/metabolismSchizophrenia/drug therapySecondary Prevention
Substances： See more » IsoxazolesPyrimidinesReceptor, Serotonin, 5-HT2AReceptors, Dopamine D2Paliperidone Palmitate
Year: 2011 PMID： 21666344 DOI： 10.1254/fpj.137.245
Source DB: PubMed Journal: Nihon Yakurigaku Zasshi ISSN： 0015-5691